Vasilios Ragos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Vasilios Ragos has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Fotopoulos
Department of Nuclear Medicine, University Hospital of Ioannina, Greece
1 shared publication - Antonio Capizzello
AHEPA Univ Hosp, Dept Radiat Oncol, 1 St Kiriakidi Str, Thessaloniki 54621, Greece
1 shared publication - Chrissa Sioka
Department of Nuclear Medicine, University Hospital of Ioannina, 45500 Ioannina, Greece
1 shared publication - Eftychia Tzima
Department of Medical Physics, University Hospital of Ioannina, Greece
1 shared publication - Ifigenia Tasiou
Department of Radiation Therapy, University Hospital of Ioannina, Greece
1 shared publication - Nikolaos Fotou
Department of Radiation Therapy, University Hospital of Ioannina, Greece
1 shared publication
Latest Publications
- Open Access
- 8 November 2011
- Published by Springer Nature in Radiation Oncology
- Vol. 6 (1) , 151
Myocardial perfusion imaging with 99 mTc - tetrofosmin SPECT in breast cancer patients that received postoperative radiotherapy: a case-control study
To evaluate the cardiac toxicity of radiotherapy (RT) in breast cancer (BC) patients employing myocardial perfusion imaging (MPI) with Tc-99 m Tetrofosmin-single photon emission computer tomography (T-SPECT). We studied 46 BC female patients (28 patients with left and 18 patients with right BC) treated with postoperative RT compared to a control group of 85 age-matched females. The median time of RT to SPECT was 40 months (6-263). Abnormalities in the summed stress score (SSS) were found in 54% of left BC patients, 44.4% of right BC patients, and 32.9% of controls. In left BC patients there were significantly more SSS abnormalities compared to controls (4.0 ± 3.5 vs 2.6 ± 2.0, p = 0.05) and possible trend of increased abnormalities of right BC patients (3.7 ± 3.0 vs 2.6 ± 2.0, p = 0.14). Multiple regression analysis showed more abnormalities in the MPI of left BC patients compared to controls (SSS, p = 0.0001); Marginal toxicity was also noted in right BC patients (SSS, p = 0.045). No additional toxicity was found in patients that received adjuvant cardiotoxic chemotherapy. All T-SPECT abnormalities were clinically silent. The study suggests that radiation therapy to BC patients result in MPI abnormalities but without apparent clinical consequences.
- 8 November 2011
- Published by Springer Nature in Radiation Oncology
- Vol. 6 (1) , 151
Open AccessMyocardial perfusion imaging with 99 mTc - tetrofosmin SPECT in breast cancer patients that received postoperative radiotherapy: a case-control study
To evaluate the cardiac toxicity of radiotherapy (RT) in breast cancer (BC) patients employing myocardial perfusion imaging (MPI) with Tc-99 m Tetrofosmin-single photon emission computer tomography (T-SPECT). We studied 46 BC female patients (28 patients with left and 18 patients with right BC) treated with postoperative RT compared to a control group of 85 age-matched females. The median time of RT to SPECT was 40 months (6-263). Abnormalities in the summed stress score (SSS) were found in 54% of left BC patients, 44.4% of right BC patients, and 32.9% of controls. In left BC patients there were significantly more SSS abnormalities compared to controls (4.0 ± 3.5 vs 2.6 ± 2.0, p = 0.05) and possible trend of increased abnormalities of right BC patients (3.7 ± 3.0 vs 2.6 ± 2.0, p = 0.14). Multiple regression analysis showed more abnormalities in the MPI of left BC patients compared to controls (SSS, p = 0.0001); Marginal toxicity was also noted in right BC patients (SSS, p = 0.045). No additional toxicity was found in patients that received adjuvant cardiotoxic chemotherapy. All T-SPECT abnormalities were clinically silent. The study suggests that radiation therapy to BC patients result in MPI abnormalities but without apparent clinical consequences.